RAPT Therapeutics, Inc. (RAPT) Non-Current Assets (2020 - 2024)
RAPT Therapeutics (RAPT) has disclosed Non-Current Assets for 5 consecutive years, with $5.9 million as the latest value for Q3 2024.
- Quarterly Non-Current Assets fell 53.37% to $5.9 million in Q3 2024 from the year-ago period, while the trailing twelve-month figure was $31.6 million through Sep 2024, down 40.66% year-over-year, with the annual reading at $11.5 million for FY2023, 14.56% down from the prior year.
- Non-Current Assets hit $5.9 million in Q3 2024 for RAPT Therapeutics, down from $6.7 million in the prior quarter.
- In the past five years, Non-Current Assets ranged from a high of $13.7 million in Q1 2023 to a low of $3.0 million in Q3 2021.
- Historically, Non-Current Assets has averaged $7.9 million across 5 years, with a median of $6.7 million in 2024.
- Biggest five-year swings in Non-Current Assets: skyrocketed 290.8% in 2022 and later crashed 53.37% in 2024.
- Year by year, Non-Current Assets stood at $3.4 million in 2020, then soared by 67.99% to $5.7 million in 2021, then surged by 138.65% to $13.5 million in 2022, then decreased by 14.56% to $11.5 million in 2023, then plummeted by 49.19% to $5.9 million in 2024.
- Business Quant data shows Non-Current Assets for RAPT at $5.9 million in Q3 2024, $6.7 million in Q2 2024, and $7.5 million in Q1 2024.